Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$165K Sell
613
-1,147
-65% -$286K 0.02% 311
2023
Q2
$391K Sell
1,760
-317
-15% -$73.6K 0.04% 222
2023
Q1
$502K Buy
+2,077
New +$510K 0.05% 189
2022
Q2
$339K Sell
1,392
-289
-17% -$70.8K 0.04% 228
2022
Q1
$406K Buy
+1,681
New +$386K 0.04% 231
2021
Q4
Sell
-8,722
Closed -$1.85M 322
2021
Q3
$1.85M Buy
8,722
+164
+2% +$37.7K 0.2% 118
2021
Q2
$2.09M Buy
8,558
+488
+6% +$120K 0.22% 98
2021
Q1
$2.01M Buy
8,070
+1,941
+32% +$463K 0.25% 95
2020
Q4
$1.41M Buy
6,129
+1,103
+22% +$254K 0.22% 91
2020
Q3
$1.28M Sell
5,026
-1,405
-22% -$348K 0.25% 89
2020
Q2
$1.52M Buy
+6,431
New +$1.47M 0.37% 53
2019
Q2
Sell
-410
Closed -$78K 194
2019
Q1
$78K Buy
+410
New +$78.3K 0.03% 275
2018
Q4
Sell
-807
Closed -$167K 219
2018
Q3
$167K Buy
807
+430
+114% +$84.7K 0.07% 191
2018
Q2
$70K Buy
+377
New +$66.7K 0.03% 308
2018
Q1
Sell
-375
Closed -$65K 279
2017
Q4
$65K Buy
+375
New +$66.4K 0.03% 349

Other funds holding AMGN

Icon Wealth Partners's AMGN Position: Q3 2023 in Review

Icon Wealth Partners reduced its Amgen (AMGN) stake by 65% in Q3 2023, selling an estimated $286K and leaving 613 shares worth $165K. The position accounts for 0.02% of the portfolio, ranked #311.

Icon Wealth Partners first reported a position in AMGN in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.09M in Q2 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Icon Wealth Partners held 613 shares of Amgen worth $165K as of Q3 2023.
  • Icon Wealth Partners sold 1,147 Amgen shares in Q3 2023, an estimated $286K.
  • Amgen made up 0.02% of Icon Wealth Partners's portfolio in Q3 2023, its #311 holding.
  • Icon Wealth Partners first reported a position in Amgen in Q4 2017 and has held it in 15 quarters since.
  • Icon Wealth Partners's Amgen position peaked at $2.09M in Q2 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.